Search
Now showing items 1-5 of 5
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
(Elsevier, 2015)
This paper empirically examines the consumer welfare implications of changes in government policies related to patent protection and compulsory licensing in the Indian market for oral anti-diabetic (OAD) medicines. In ...
Competition law in india: perspectives
(Sage, 2016)
In 2002, the Parliament of India enacted the Competition Act, replacing the
archaic Monopoly and Restrictive Trade Practices Act (popularly referred to as
the MRTP Act) of 1969. The primary goal of the Act, as stated in ...
Crocin or paracetamol: what should the doctor prescribe?
(Economic & Political Weekly, 2013)
As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes ...
Balancing affordability and availability in a drug patent regime
(Economic and Political Weekly, 2015)
India needs to fi
nd an optimal
patenting regime that will
safeguard incentives for
innovation while simultaneously
ensuring that medicines are
available at reasonable prices.
The Welfare Implications of Patent Protection, Pricing and Licensing in the Indian Oral Anti-Diabetic Market
(Indian Institute of Management Ahmedabad, 2013)
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 ...